# US 2002/0058018 A1 · Novel interleukin-3 and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0058018 A1
- Document ID: US20020058018A1
- Status: Published application
- Kind: A1
- Application number: 09/792,246
- Filed: 2001-02-23
- Published: 2002-05-16
- Earliest claimed: 1999-08-17
- Assignees: Hyseq, Inc.
- Inventors: John Ford
- Web page: https://patentgrep.com/patent/US20020058018A1

## CPC

- C07K 14/5403: {IL-3}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides novel nucleic acids isolated from a cDNA library for fetal liver-spleen tissue, and the novel polypeptide sequences encoded by these nucleic acids. These novel polynucleotide and polypeptide sequences were determined to be a novel Interleukin-3.

## Claims

### Claim 1

An isolated polynucleotide comprising:
(a) the nucleotide sequence of SEQ ID NO: 1;
(b) the nucleotide sequence of SEQ ID NO: 2; or
(c) a nucleotide sequence encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 3.

### Claim 2 (depends on 1)

An isolated polynucleotide which hybridizes to the complement of the polynucleotide of claim 1 under stringent hybridization conditions.

### Claim 3 (depends on 1)

An isolated polynucleotide which comprises the complement of the polynucleotide of claim 1.

### Claim 4 (depends on 1)

A vector comprising the isolated polynucleotide of claim 1.

### Claim 5 (depends on 1)

An expression vector comprising the isolated polynucleotide of claim 1.

### Claim 6 (depends on 1)

A host cell genetically engineered to contain the polynucleotide of claim 1.

### Claim 7 (depends on 1)

A host cell genetically engineered to contain the polynucleotide of claim 1 in operative association with a regulatory sequence that controls expression of the polynucleotide in the host cell.

### Claim 8

An isolated polypeptide comprising the amino acid sequence of SEQ ID NO: 3.

### Claim 9 (depends on 8)

A composition comprising the polypeptide of claim 8 and a carrier.

### Claim 10 (depends on 8)

An antibody directed against the polypeptide of claim 8.

### Claim 11 (depends on 1)

A method for detecting a polynucleotide of claim 1 in a sample, comprising:
a) contacting the sample with a compound that binds to and forms a complex with the polynucleotide for a period sufficient to form the complex; and
b) detecting the complex, so that if a complex is detected, a polynucleotide of claim 1 is detected.

### Claim 12 (depends on 1)

A method for detecting a polynucleotide of claim 1 in a sample, comprising:
a) contacting the sample under stringent hybridization conditions with nucleic acid primers that anneal to a polynucleotide of claim 1 under such conditions; and
b) amplifying the polynucleotides of claim 1 so that if a polynucleotide is amplified, a polynucleotide of claim 1 is detected.

### Claim 13 (depends on 8, 12)

The method of claim 12, wherein the polynucleotide is an RNA molecule that encodes a polypeptide of claim 8, and the method further comprises reverse transcribing an annealed RNA molecule into a cDNA polynucleotide.

### Claim 14 (depends on 8)

A method for detecting a polypeptide of claim 8 in a sample, comprising:
a) contacting the sample with a compound that binds to and forms a complex with the polypeptide for a period sufficient to form the complex; and
b) detecting the complex, so that if a complex is detected, a polypeptide of claim 8 is detected.

### Claim 15 (depends on 8)

A method for identifying a compound that binds to a polypeptide of claim 8, comprising:
a) contacting a compound with a polypeptide of claim 8 for a time sufficient to form a polypeptide/compound complex; and
b) detecting the complex, so that if a polypeptide/compound complex is detected, a compound that binds to a polypeptide of claim 8 is identified.

### Claim 16 (depends on 8)

A method for identifying a compound that binds to a polypeptide of claim 8, comprising:
a) contacting a compound with a polypeptide of claim 8, in a cell, for a time sufficient to form a polypeptide/compound complex, wherein the complex drives expression of a reporter gene sequence in the cell; and
b) detecting the complex by detecting reporter gene sequence expression, so that if a polypeptide/compound complex is detected, a compound that binds to a polypeptide of claim 8 is identified.

### Claim 17 (depends on 7, 8)

A method of producing the polypeptide of claim 8, comprising,
a) culturing the host cell of claim 7 for a period of time sufficient to express the polypetide contained within said cell; and
b) isolating the peptide from the cell of step (a).

### Claim 18

A method of stimulating differentiation in a hematopoietic precursor cell, comprising contacting the hematopoietic precursor cells with a polypeptide of SEQ ID NO: 3 for a time sufficient to promote differentiation of the hematopoietic precursor cell.

### Claim 19 (depends on 18)

The method of claim 18, wherein the hematopoietic precursor cells are contacted with a polypeptide of SEQ ID NO: 3 in vitro.

### Claim 20 (depends on 19)

The method of claim 19, wherein the hematopoietic precursor cell is a hemopoietic stem cell.

### Claim 21 (depends on 19)

The method of claim 19, wherein the hematopoietic precursor cell is a hemopoietic progenitor cell.

### Claim 22 (depends on 19)

The method of claim 19, wherein the hematopoietic precursor cell is a lymphoid or myloid cell.

### Claim 23 (depends on 22)

The method of claim 22, wherein the myloid cell is a monocyte cell.

### Claim 24 (depends on 19)

The method of claim 19, wherein the hematopoietic precursor cell differentiates into a dendritic-like cell.
